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Abstract: The optoelectronic sensor OPT101 have merits in advanced optoelectronic response
characteristics at wavelength range for medical near-infrared spectroscopy and small-size chip
design with build-in trans-impedance amplifier. Our lab is devoted to developing a series of portable
near-infrared spectroscopy (NIRS) devices embedded with OPT101 for applications in intensive
care unit clinics, based on NIRS principle. Here we review the characteristics and advantages of
OPT101 relative to clinical NIRS instrumentation, and the most recent achievements, including
early-diagnosis and therapeutic effect evaluation of thrombus, noninvasive monitoring of patients'
shock severity, and fatigue evaluation. The future prospect on OPT101 improvements in noninvasive
clinical applications is also discussed.
Keywords: optoelectronic sensor; near-infrared spectroscopy; thrombus diagnosis; shock monitoring;
fatigue evaluation
1. Introduction
Currently, optoelectronic sensors have been applied in fruit or stem growth monitoring in
agriculture [1], nitric oxide detection with high sensitivity [2], pulse oximetry for pulse rate and
oxygenation measurement [3], and salivary diagnosis of stomach cancer [4]. OPT101 (Monolithic
photodiode and single-supply transimpedance amplifier, Texas Instruments, America) is one type of
optoelectronic sensor which converts optical signal to electronic signal without additional noise [5]
and with signal amplification function. These prestigious advantages prompted OPT101 to be used in
noninvasive clinics.
There are significant requirements to develop noninvasive and smart monitoring techniques in
intensive care unit (ICU), such as for newborn babies and patients undergoing emergency care.
For instance, shock usually causes acute blood flow reduction, anaerobic metabolism, etc., and
irreversible damage and death if sustained. The inevitable hemorrhage during surgery and traumatic
injury-induced shock is known as a fatal complication with a high mortality rate of ~50% [6]. The
conventional clinical method to estimate shock severity was to measure blood oxygen indices in the
central internal jugular central vein (ScvO2) [7]. However, the intermittent and invasive procedures to
obtain this acceptable blood oxygen indicator actually prevented continuous shock monitoring, which
is crucial for clinicians to judge the best time window to rescue the patient with shock. A noninvasive,
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continuous, and smart monitoring technique is imperative. Similarly, the ‘salient killer’ deep vein
thrombosis, known as a dangerous complication after surgery especially for old patients, may cause
a large range of high-incidence diseases related to heart and cerebral vessels [8]. With noninvasive
and smart monitoring techniques, we may be able to get early detection of this disease, observe its
development, and better guide and evaluate the therapeutic effects. In addition, doctors and nurses
often suffer from long working hours and exhausting working, which might increase fatigue level and
cause undesirable accidents [9,10]. However, the current techniques in hospital were not able to offer
continuous or sensitive measurements to solve the above problems [7,11,12]. Noninvasive and smart
monitoring techniques were on demand to accelerate the working timeline.
Near-infrared spectroscopy (NIRS), with wavelength ranging from 700 nm to 900 nm, is a
noninvasive and real-time technique capable of continuously measuring hemodynamic variations
in biological tissues [10,13]. As an effective, nondestructive, and non-ionizing measurement
technique, NIRS has attracted more and more researchers’ attention. Recently, NIRS has been widely
applied in various domains of science, including agriculture monitoring [14], food test [15], drug
analysis [16], medical diagnosis [17], etc. The combination of NIRS principle and photoelectric
sensor introduced a series of NIRS instrumentations. A variety of photoelectric sensors have
been used in NIRS instrumentation [18], such as continuous-wave NIRS employed photodiode
(OPT101, Texas Instruments, Dallas, TX, USA) [6], frequency-domain NIRS employed Photomultiplier
tubes (PMTs, PicoQuant, Berlin, Germany) [19], NIRS diffuse correlation spectroscopy employed
single-photon-counting Avalanche photodiodes (APDs, Pacer, Palm Beach Gardens, FL, USA) [20],
or time-domain NIRS employed streak/time-gated intensified charge coupled device camera [21].
Although the sensitivity of OPT101 is not the highest among all the detectors, it is still known as
high-sensitivity, high gain, and low noise. Moreover, OPT101 is with higher responsivity in our NIRS
wavelengths (750 nm, 805 nm, and 850 nm), relatively smaller and cheaper than other sensors. Of
note, OPT101 can be embedded with LED light source in a soft circuit of the probe, allowing the whole
device of fNIRS to be more compact and wearable. In addition, APDs and SiPMs need more electronics
than OPT101 in application for clinical NIRS instruments. At the current stage, the continuous-wave
NIRSs (mostly, with photodiode OPT101) are much closer to clinical applications than other types
of NIRSs.
Compared to common clinics, ICU requires portable techniques at bedside, real-time and sensitive
monitoring, and noninvasive measurements, to offer patients more intensive care and timely treatment.
The advantages of noninvasive monitoring, portability, and relatively compact instrument mean
photoelectric sensor embedded continuous-wave NIRS technology is a great potential method for ICU.
Here, we attempted to integrate OPT101 in portable NIRS device, especially for ICU, and review the
successful applications achieved by our group and collaborators in recent years, some of which have
been reported in biomedical optics journals.
In this paper, we review our ICU-specific NIRS techniques with 3-wavelengths (735 nm, 805 nm,
and 850 nm) integrated LED as near-infrared light source and OPT101 as detector in instrumentation.
The optoelectronic response characteristics of OPT101 in near-infrared wavelength range (700~900 nm),
especially the three light source wavelengths in our customized NIRS device, were introduced. In
addition, the feasibility of OPT101 in sensing the signal in the measured tissue of the human body was
quantitatively analyzed with realistic light propagation modeling. Then we report the measurement
algorithms for these NIRS devices to measure disease-sensitive hemodynamic parameters. After
that, we report three successful OPT101 embedded ICU-specific NIRS devices, including one for
early-diagnosis and therapeutic effect tracking of thrombus, one for noninvasive monitoring of shock
patients’ conditions, and the other for fatigue evaluation of working medical staff with long working
hours [6,9,17,22]. Human experiments were carried out to fully test the reliabilities of these devices.
Our data showed successful application of OPT101 in ICU-specific NIRS devices and the great potential
of OPT101 in medicine and home healthcare.
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2. Methods and Materials
2.1. Photoelectric Detector OPT101 and Applicable Probe Design
The photoelectric detector OPT101 (Figure 1a) is a kind of integrated photodiode with on-chip
built-in transimpedance amplifier. The amplifier is designed for single or dual power-served
operation, applicable to a battery-include instrument. The integration design of photodiode and
a trans-impedance amplifier on a chip may effectively reduce current leakage, noise and stray
capacitance-induced gain peaking. Besides, in photoconductive mode, the 8.1× 10−3 inch2 photodiode
offer fairly high linearity and very low dark current. Quantitatively, the working voltage of the OPT101
ranges from 2.7 V to 36 V and its quiescent current is only 120 µA. For the circuitry design of OPT101,
the bandwidth at an external 5 MΩ feedback resistor and an external 10 pF capacitor is 2.5 kHz.
The DC gain and the actual working voltage are 6 × 106 V/A and 5 V respectively. As shown in
the special responsivity curve in Figure 1b and Table 1, the responsivity of OPT101 at the specified
wavelengths (735 nm, 805 nm, and 850 nm) are close to the peak value around 86%, which is higher
than SiPM sensors (~5%) and APD sensors (~80%) and allows high sensitivity in sensing the light at
these wavelengths.
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Table 1 shows the comparisons on the negatives and positives of OPT101 and other optoelectronic
sensors used in NIRS instrumentation. Among all optoelectronic sensors listed, the sensitivity of
OPT101 does not stand out; however, it is still high enough to sensitively measure hemodynamic
variations in human body noninvasively. Additionally, OPT101 is of high gain and low cost. Plus,
OPT101 has a built-in transimpedance amplifier and does not need any more electronics in clinical
NIRS instrumentation, unlike APDs and SiPMs. It can be simply embedded with LEDs in a soft
electronic circuit pad, making NIRS more portable and even wearable. The advantages of OPT101,
including sensitive-enough responsivity, mini-size structure, advanced electronic properties, and
low cost, make it quite suitable for our bedside care instrument design in recording light intensity
variations at selected wavelengths to measure human body hemodynamics.
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Table 1. Comparison of OPT101 and other optoelectronic sensors in near-infrared spectroscopy
(NIRS) instrumentation.
Characteristics APDs SiPMs OPT101 Ref.
Rough price $40~500 $25~120 $2~13 [23–26]
Rough diameter (mm) ~3 3, 5, or 6 2 [27–29]
Sensitive wavelength
range (nm) 400~1100 220~900 400~1100 [29–31]
Efficiency up to 85% up to 45% up to 90% [27,29–32]
Efficiency at 800 nm ~80% 5% 86% [29–33]
Gain 100 107 106 [27,29,34]
Noise current 100 nA - 2.5 pA [27,29]
Feature
Good performance
at high noise of
the amplifier
Good time
resolution
High quantum efficiency,
on-chip built-in
transimpedance amplifier
[28,29,31]
Weakness
Not work at very
low bandwidth or
low noise of
the amplifier
The afterpulsing
peak against
autocorrelation
function analysis
Lower time resolution
than SiPMs, lower
sensitivity than APDs
[28,31]
Here, OPT101 was utilized to collect light intensity signals in a certain measurement site of the
human body and it converted the collected optical signals to electrical signals, such as voltage signal.
The output voltage response was recorded, transferred to physiological variations, and displayed in our
customized NIRS software. In our NIRS instruments with OPT101, calibration for OPT101 separately
or for each sensor array configuration is not essential, which is required by absolute measurements.
Based on the linear optoelectronic response and linear amplifier response, the output voltage response
of OPT101 increases linearly with light intensity. The reason for this is that we actually obtain the
optical density variation from the ratio of detected light intensity variation sequence to the initial
detected light intensity baseline, which belongs to relative measurements.
Figure 1c–f shows the probe designs with the optoelectronic detector embedded, for the
applications of handhold curved scanning health detector (c), thrombosis detector (d), fatigue monitor
(e), and shock status reporter (f). The quantities of detectors, the separations between the light sources
and detectors, and the configurations of the light sources and detectors were different among the above
applications, according to the measurement region of interest, surface geometry and data processing
algorithm. For example, the handhold curved scanning health detector in Figure 1c was specially
designed for measuring legs, arms, and breast with round-like geometry, thus the probe surface was
designed as curved with those tissues. Separation of light sources and detectors was 2.5 cm, which
was the mean of the optimized value applicable to the measured body tissue. Additionally, this
detector application was of relative bilateral comparison measurement. Accordingly, the contralateral
placement of the two OPT101 beside the light source was employed.
The detectors for thrombus, fatigue and shock were designed in a flexible printed circuit board
with black blocking leather attached on either sites, which allowed the detectors and detecting surface
to be fully and tightly attached to measure skin regions. This design effectively reduced the background
noise and signal leak. The curved detector was made in a rigid circuit board design and hard
encapsulated, which is easy to hold in the hand to scan on the surface of different body tissues.
During designing the detector probe as described above, the signal to noise ratio was the key
concern for the optoelectronic detector application. Here, we addressed this issue by taking the human
head, the most complicated tissue structure, as an example. By using the approach of Monte Carlo
light propagation modeling within voxelized tissue media [35], we computed out signal sensitivity
distribution (SSD) map (Figure 2) within the Visible Chinese Human [36–38] head model. The SSD
map was shown in a pseudo color map with quantitative contours. The SSD data demonstrate that
the separation scale of the light sources and detectors approved the detectable depth within tissue
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to be more than 3 cm, when the signal to noise ratio was higher than the limit of the OPT101 sensor,
which is 1 × 10−7. Moreover, the accumulated light signal from the tissue region that was deeper than
3 cm was higher than 1.27 × 10−6 of the incident light, which also supported the sensitive and reliable
sensing of light signal from the interrogated tissue volume by detector OPT101. In addition, with the
usage of OPT101, fNIRS technology can be realized in a portable, compact, and compatible design.
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OPT101 involved NIRS ICU-specific devices. In detail, the detected light intensity (I) signal by OPT101
originated from the light traveling through the measured tissue is converted to optical density (OD) by
the following equation:
OD = − log I
I0
= − log U
U0
(1)
where I0 is the initial light intensity. U0 and U are the initial converted voltage and the converted
voltage signal responding to I0 and I, respectively. By using the least square fitting method, and
treating the optical density as ordinate and the distance between source and sensor as abscissa, the
relationship between the light diffusion factor at wavelength λi (D(λi)) and the slope (S(λi)) can be
extracted as follows [9]:
D(λi) = 2.3S(λi) + D(SS) (2)
Here, D(SS) is the light diffusion factor of standard sample. The absolute concentrations of HbO2
([HbO2]) and Hb ([Hb]) are calc lated by the following equations [6,9]:
C[HbO2] =
εHbO2(λ1)µ
′
t(λ1)D
2(λ2) − εHbO2(λ2)µ
′
t(λ2)D
2(λ1)
3µ′t(λ1)µ′t(λ2)ln 10
[
εHb(λ2)εHbO2(λ1) − εHb(λ1)εHbO2(λ2)
] (3)
C[Hb] =
εHb(λ1)µ
′
t(λ1)D
2(λ2) − εHb(λ2)µ′t(λ2)D2(λ1)
3µ′t(λ1)µ′t(λ2)ln 10
[
εHb(λ2)εHbO2(λ1) − εHb(λ1)εHbO2(λ2)
] (4)
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where εHbO2(λ i
)
and εHb(λ i) are the extinction coefficients of HbO2 and Hb at wavelength λi,
respectively. And in our applications, we utilized 735 nm and 850 nm for HbO2 and Hb quantification.
The light attenuation factor at wavelength λi, µ′t(λ i) is calculated by [9]:
µ′t(λi) =
10ln (λi)µ′t(SS)
[
2.3S(λi) + D(SS) +
(
1
r0
)]
D(SS) +
(
1
r0
) (5)
µ′t(SS) is the light attenuation of standard sample. The [HbO2] and [Hb] relative to the initial
values (∆[HbO2] and ∆[Hb] respectively) are given below [9,39]:
∆[HbO2] =
εHb(λ1)∆µa(λ2) − εHb(λ2)∆µa(λ1)
εHb(λ1)εHbO2(λ2) − εHb(λ2)εHbO2(λ1)
(6)
∆[Hb] =
εHbO2(λ2)∆µa(λ1) − εHbO2(λ1)∆µa(λ2)
εHb(λ1)εHbO2(λ2) − εHb(λ2)εHbO2(λ1)
(7)
Here, ∆µa(λ) is the relative change of medium absorption coefficient at wavelength λ.
2.3. ICU-Specific NIRS Device and Experiment Test
The novel applications of OPT101 as photoelectric detector for ICU-specific NIRS device
development in our lab were illustrated by thrombus diagnosis and monitoring, patient shock status
monitoring, and fatigue evaluation in this paper. All these applications generated devices consisted
of three parts, which were the optical probe, control circuit module, and data analysis software. The
light source was a 3-wavelength (735 nm, 805 nm, and 850 nm) integrated LED. All the work of data
collection was approved by the ethics committee (Approval No. XHECD-2014-005).
2.3.1. Thrombus Diagnosis and Monitoring
Thrombus is a severe complication which may cause serious morbidity and mortality, and usually
happens in patients and the postoperative population. Most patients with thrombus are at risk of
developing post thrombotic dysfunctions, leading to long-term morbidity and induce ulceration,
chronic swelling, skin damage, and other clinical manifestations. However, the conventional diagnosis
relies on sophisticated imaging methodologies which may also induce invasive contrast agent injection
and ionizing procedure [11,12]. We proposed to develop a portable NIRS under patients’ resting state
for thrombus diagnosis, monitoring, and therapeutic effect evaluation [17,22].
The OPT101 embedded NIRS device is shown in Figure 3. Figure 3a shows the real scene where
we collected the data from a patient suffering from thrombus on clinic field monitoring. Figure 3b
shows our custom device design and Figure 3c shows the placement of the light source and detector in
the probe. Figure 3a also illustrates the use of the device. The probe included one light source and six
detectors surrounding it. The light source and detectors were driven by a control circuit module to
emit 735 nm and 850 nm light, and the control module collected signals from the OPT101 detectors
at a set of timing sequence. The distance between light source and OPT101 detectors was 2.8 cm,
enabling most signals coming from the muscle layer in the early thrombus tissue, such us legs and
arms. We attempted to explore if the values of ∆[HbO2] and ∆[Hb] could reflect the occurrence or state
of thrombus.
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(c) connection diagram.
We collected data from nine patients with thrombosis during and after therapy and from
seven healthy subjects for contrast. We analyzed these data and drew the scatterplot histograms
of ∆[HbO2]/∆[Hb] for statistical comparisons b tween both populations. Th bolytic therapy was
taken on patients eve y other ay. We lso used our devic to coll ct ∆[HbO2] from one day before
and during the treatment days to analyze the therapeutic effects between thrombus and healthy legs.
2.3.2. Monitoring Patients with Shock
The fatal risk of shock resulting from trauma and hemorrhage is usually high, up to 50% mortality
rate according to reports [40,41]. However, t e current clinic techniques to me sure shock severity of
patients who suffered from intermitten a d invasive procedures, which could not allow clinicians to
judge the best time to rescue the patients. We developed a portable space-resolved NIRS device for
bedside monitoring of patients with shock.
In this application, we recommended the tissue blood oxygen saturation (StO2) measured in the
tissue surrounding the central internal jugular central vein as an indicator for shock severity. The value
of StO2 was calculated by [HbO2] and [Hb] as follows:
StO2 =
C[HbO2]
C[HbO2] + C[Hb]
× 100% (8)
Compared to thrombus diagnosis, the NIRS monitor for patients with shock (Figure 4a) offered
the measurement of physiological parameters in the lateral neck region (Figure 4c). The design of a
flexible optical probe was space-resolved (Figure 4b), allowing absolute measurement of [HbO2] and
[Hb]. Figure 4a shows the device for shock monitoring.
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There were one near-infrared light source and two detectors on the probe of the monitor for
patients with shock. The distances between the light source and the two OPT101 detectors were slightly
different, r1 and r2 respectively. The angle from one detector to the other regarding the source point as
the center was α. The value of α varied at the range of 0◦ to 13.5◦. Moreover, the typical value of the
angle was between 4.5◦ and 9.5◦. The set of the angle was due to the two restrictions, which were the
safe distance between OPT101 and slight difference between r1 and r2. With the differential set of r1
and r2, as well as the absolute measure algorithm, we were able to obtain the measurement of StO2 in
the shock-status-sensitive region, the tissue surrounding the central internal jugular central vein. We
acquired data from 12 patients one day after shock treatment. For comparison, we analyzed not only
StO2, but also ScvO2 which was a golden standard indicator for shock prediction, by linear analysis
and Bland-Altman plot [6].
2.3.3. Fatigue Evaluation
The doctors and nurses usually work long hours in the ICUs, accordingly fatigue becomes a severe
problem requiring quantitative management and proper intervention. Here we focused on the fatigue
induced by prolonged work or operation. A computer game playing paradigm was used to induce the
ICU clinicians’ working fatigue. We recruited 10 healthy subjects to play computer games for 7 h with
a realistic driving simulator platform as shown in Figure 5a. Subjects were instructed to take visual
selective attention test every hour during the whole 7-h computer game. We collected brain activities
data with a portable NIRS imager (probe shown in Figure 5b) attached on the subjects’ foreheads at
the beginning of driving and then every 1 h (Figure 5a). The brain activity response was interpreted by
hemodynamic recordings ([HbO2] and [Hb]) based on the neurovascular coupling theory. The data of
variations of [HbO2] and [Hb] recorded in the attention test was used to test whether it could be used
for fatigue evaluation. As shown in Figure 5b, the probe of fatigue evaluation contains a near-infrared
light source and 20 detectors, which allows 8 channels of detection and reducing artifact from skin by
the nearest detector to the source and absolute measurements of ∆[HbO2] and ∆[Hb]. Figure 5c shows
a picture of our customized NIRS device for fatigue evaluation.
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uring I S data recording, e also recorded the response of subjects to the attention sti uli
on keyboard and reaction ti e. For data analysis, we composited the mean behavioral factor from
10 subjects at every attention test as accuracy/RT to quantify the mental fatigue of subjects. Then e
analyzed the relationship between the hemodynamic parameters and the behavioral data accuracy/RT
following with the fatigue increment induced by computer game playing. We also computed the
prefrontal activation map with fatigue degree increase for intuitively visualizing fatigue adjustment
on prefrontal activity.
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3. Results
3.1. Thrombus Diagnosis and Therapeutic Effect Evaluation
Figure 6a shows a comparison of the composed hemodynamic parameter ∆[HbO2]/∆[Hb]
between the normal subjects and thrombus patients. In general, the value of ∆[HbO2]/∆[Hb] of
the normal subjects (11.0 ± 0.95) are higher than those of the thrombus patients (9.6 ± 1.10). Student
t-test also shows that the above measurements are dramatically different between normal subjects
and thrombus patients (p < 0.001). On the other side, Figure 6b shows the hemodynamic response
to therapeutic effect. The value of ∆[HbO2] in thrombus legs decreases after therapy, and increases
gradually during the recovery phase and finally reaches a significantly higher value after two days
post treatment. For a healthy leg, the value of ∆[HbO2] recovers to the initial state in one day and
then remains stable after the therapy. Accordingly, the hemodynamic response monitored by our
noninvasive NIRS thrombus monitor is shown to be capable of differentiating thrombus region
from health region of human body and evaluating the therapeutic effect, either from the composed
hemodynamic parameter (∆[HbO2]/∆[Hb]) or the relatively more sensitive indicator (∆[HbO2]).
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3.3. Fatigue Evaluation and Data
As for fatigue evaluation, Figure 8 shows that both the prefrontal activity induced ∆[HbO2]
measured by NIRS imager and the behavioral performance factor accuracy/RT varied nonlinearly
along with the time duration of playing the computer game. Figure 8a displays the prefrontal activation
map followed by the continuous computer game duration. The pseudo color map shows that the
amplitude of the activation increases gradually in the prefrontal lobe, especially in the middle bottom
prefrontal region, which is highlighted in a black rectangular box in the map (Figure 8a). After
we extracted the mean value of brain activation in terms of ∆[HbO2] of every subject, we plot its
variation with duration time statistically, as well as the behavioral performance. We find that the
fatigue-induced ∆[HbO2] rise up while fatigue-induced behavioral performance fall down in a similar
opposite tendency (Figure 8b). Interestingly, the statistical mean ∆[HbO2] and accuracy/RT shows a
strong negative linear correlation (R = −0.896, p = 0.002).
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4. Conclusions and Discussion
With the optoelectronic detector OPT101, we innovatively developed a series of NIRS devices for
ICU, including the common health scanner, the thrombus monitor, monitor for patients with shock,
and the imager for fatigue evaluation. All of these devices were noninvasive, portable, compact, and
real-time. These devices surpassed the current methods or conventional techniques used in those
severe diseases in integrated advantages of noninvasive, nonionizing, and continuous measurements.
The experimental studies of each device displayed good reliability and sensitivity. The whole study
fully demonstrated the medical and life science application of OPT101 in near-infrared spectroscopy,
and indicated the great potential of OPT101, as well as the feasibility of OPT101 embedded portable
NIRS in ICU and multifunctional home health care.
Our study on thrombus monitor showed that NIRS monitoring of ∆[HbO2]/∆[Hb] played a fairly
sensitive role in diagnosis of thrombus, as well as the therapeutic effect tracking and evaluation. Of
note, the monitor probe was applicable to the early thrombosis tissues, such as legs, which indicated
the home care use of this device in early detection and development of thrombosis. In the application
of monitoring patients with shock, we found that the StO2 measured in the tissue surrounding
the central jugular vein is quite consistent with the golden standard indicator ScvO2, which was
measured by blood drop sampling and blood-gas analysis. Apparently, the ScvO2 could not be
measured continuously and in real time, which means that it was actually not possible to monitor
shock and to predict the time window for rescuing the patients. In contrast, StO2 measured by
NIRS shock monitoring was quite appropriate for monitoring the onset of the shock and severity
change of the shock. For fatigue evaluation, the variation ∆[HbO2] measured by the NIRS fatigue
imager increased with the working time and were highly negatively correlated with fatigue-adjusted
behavioral performance score (R =−0.899, p = 0.0026). This finding strongly supported the quantitative
evaluation of fatigue in a noninvasive and in-situation way by NIRS.
In the future, we would like to expand the range of OPT101 embedded NIRS for more applications
in life science. The sensitivity of OPT101 is expected to be closer and closer to the expensive
sensors in other kinds of NIRS instruments, which may make the NIRSs compact, low-cost, and
close-to-translational as well. In addition, according to Table 1, the SiPM sensor has been developed to
be smaller and smaller and with good characteristics, especially high time resolution, which suggests
great potential in compact time-resolved or correlational NIRS.
Additionally, even OPT101 is small enough at the current stage, it is also expected to be in patch
type design in the near future, which would allow the flexible and wearable design of the above NIRS
devices for smarter healthcare.
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